121 related articles for article (PubMed ID: 10515396)
1. Long acting inhaled beta2-agonists: anti-inflammatory effects not evident during treatment of day to day asthma.
Durham S
Eur Respir J; 1999 Aug; 14(2):249-50. PubMed ID: 10515396
[No Abstract] [Full Text] [Related]
2. The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma.
Roberts JA; Bradding P; Britten KM; Walls AF; Wilson S; Gratziou C; Holgate ST; Howarth PH
Eur Respir J; 1999 Aug; 14(2):275-82. PubMed ID: 10515401
[TBL] [Abstract][Full Text] [Related]
3. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of long-acting beta2-adrenoceptor agonism.
Lipworth BJ
Br J Clin Pharmacol; 2002 Sep; 54(3):231-45. PubMed ID: 12236842
[TBL] [Abstract][Full Text] [Related]
5. Salmeterol xinafoate in asthma.
Palmer JB; Oxford JM
JAMA; 1994 Nov 23-30; 272(20):1575-6. PubMed ID: 7966861
[No Abstract] [Full Text] [Related]
6. Fluticasone propionate/salmeterol combination.
Lipworth BJ
J Allergy Clin Immunol; 2001 Apr; 107(4):746. PubMed ID: 11295673
[No Abstract] [Full Text] [Related]
7. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
Fish JE; Israel E; Murray JJ; Emmett A; Boone R; Yancey SW; Rickard KA
Chest; 2001 Aug; 120(2):423-30. PubMed ID: 11502639
[TBL] [Abstract][Full Text] [Related]
8. [Combination treatment with inhaled corticosteroid/long-acting beta 2-adrenergic bronchodilator in the treatment of asthma].
Kimura T; Adachi M
Nihon Rinsho; 2001 Oct; 59(10):1992-9. PubMed ID: 11676144
[TBL] [Abstract][Full Text] [Related]
9. Effect of short- and long-acting inhaled beta2-agonists on exhaled nitric oxide in asthmatic patients.
Yates DH; Kharitonov SA; Barnes PJ
Eur Respir J; 1997 Jul; 10(7):1483-8. PubMed ID: 9230234
[TBL] [Abstract][Full Text] [Related]
10. Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.
Busse W; Nelson H; Wolfe J; Kalberg C; Yancey SW; Rickard KA
J Allergy Clin Immunol; 1999 Jun; 103(6):1075-80. PubMed ID: 10359889
[TBL] [Abstract][Full Text] [Related]
11. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
[TBL] [Abstract][Full Text] [Related]
12. Salmeterol xinafoate in the treatment of mild to moderate asthma in primary care. UK Study Group.
Jones KP
Thorax; 1994 Oct; 49(10):971-5. PubMed ID: 7974313
[TBL] [Abstract][Full Text] [Related]
13. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
[TBL] [Abstract][Full Text] [Related]
14. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency.
Palmqvist M; Persson G; Lazer L; Rosenborg J; Larsson P; Lötvall J
Eur Respir J; 1997 Nov; 10(11):2484-9. PubMed ID: 9426083
[TBL] [Abstract][Full Text] [Related]
15. Summaries for patients. What are the risks of using inhaled long-acting beta-agonist medications for the relief of asthma?
Ann Intern Med; 2006 Jun; 144(12):I30. PubMed ID: 16785474
[No Abstract] [Full Text] [Related]
16. Efficacy of salmeterol xinafoate in the treatment of COPD.
Mahler DA; Donohue JF; Barbee RA; Goldman MD; Gross NJ; Wisniewski ME; Yancey SW; Zakes BA; Rickard KA; Anderson WH
Chest; 1999 Apr; 115(4):957-65. PubMed ID: 10208192
[TBL] [Abstract][Full Text] [Related]
17. Dose equivalence of drugs for asthma.
Fuller RW
BMJ; 1993 Apr; 306(6884):1066-7. PubMed ID: 8098239
[No Abstract] [Full Text] [Related]
18. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.
Wiegand L; Mende CN; Zaidel G; Zwillich CW; Petrocella VJ; Yancey SW; Rickard KA
Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544
[TBL] [Abstract][Full Text] [Related]
19. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
Yates DH; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
[TBL] [Abstract][Full Text] [Related]
20. [More asthma death cases with beta-2-antagonists: with inhaled corticosteroids on the safe side?].
Wepner U
MMW Fortschr Med; 2007 Dec; 149(49-50):20. PubMed ID: 18240436
[No Abstract] [Full Text] [Related]
[Next] [New Search]
